惠泰醫療(688617.SH):啟明創智及其一致行動人持股比例由11.02%減至10.01%
格隆匯11月16日丨惠泰醫療(688617.SH)公佈,公司於2022年11月16日收到公司股東啟明創智及其一致行動人啟華三期、啟明融科、啟明融盈的出具的《關於減持權益變動達到1%的吿知函》。上述股東近期累計減持67.27萬股,減持比例1.009%。
此次權益變動後,股東蘇州啟明創智股權投資合夥企業(有限合夥)(簡稱“啟明創智”)及其一致行動人蘇州工業園區啟華三期投資中心(有限合夥)(“啟華三期”)、蘇州工業園區啟明融科股權投資合夥企業(有限合夥)(簡稱“啟明融科”)、蘇州啟明融盈創業投資合夥企業(有限合夥)(簡稱“啟明融盈”)持有公司的股份數量從7,348,051股減少至6,675,351股,佔公司總股本的比例由11.0215%減少至10.0125%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.